International Stem Cell (ISCO) Price to Earnings (2010 - 2026)

International Stem Cell (ISCO) has reported Price to Earnings for 17 consecutive years, with 21.42 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Earnings fell 212.06% year-over-year to 21.42 in Q2 2026; TTM through Jun 2026 was 4.71, a 11.03% decrease from a year earlier, with the FY2025 full-year figure at 2.68, up 10.83% from the prior year.
• Price to Earnings was 21.42 for Q2 2026 at International Stem Cell, down from 3.22 in the prior quarter.
• Over five years, Price to Earnings peaked at 53.36 in Q4 2024 and troughed at 1640.9 in Q2 2022.
• A 5-year average of 117.15 and a median of 3.74 in 2024 frame the typical range for Price to Earnings.
• Across the five-year window, Price to Earnings tumbled 13515.67% in 2022 and soared 5188.89% in 2024, its largest moves.
• Over 5 years, Price to Earnings stood at 51.46 in 2022, then tumbled by 102.04% to 1.05 in 2023, then soared by 5188.89% to 53.36 in 2024, then tumbled by 106.03% to 3.22 in 2025, then sank by 565.19% to 21.42 in 2026.
• The last three Price to Earnings figures came in at 21.42 (Q2 2026), 3.22 (Q4 2025), and 35.88 (Q3 2025), per Business Quant data.